Introduction
A key feature of the immune system is its ability of selfnonself discrimination, which is required for eliminating invading pathogenic microbes while maintaining immunological tolerance to self-antigen. During thymic development of T cells, immature thymocytes express a highly diverse repertoire of αβ T cell receptors (TCRs), including potentially harmful specificities for self-antigen. Self-reactive T cells produced in thymus are rendered self-tolerant by the mechanisms of central and peripheral tolerance. These cells are deleted in the thymus and, when they have escaped the deletion, are rendered anergic or suppressed by other T cells so as not to become activated or expanded. Among these mechanisms of self-tolerance, accumulated evidence indicates that dominant suppression by regulatory T cells (Treg cells) is essential for establishing and sustaining self-tolerance and immune homeostasis.
A direct demonstration of the role of immunosuppressive CD4 + T cells in self-tolerance is that depletion of a CD4 + subpopulation from normal rodents produces autoimmune disease, and the reconstitution of the depleted population suppresses the disease development. Efforts to characterize such naturally present autoimmune-suppressive population by expression levels of cell surface molecules have revealed that it constitutively expresses CD25 (interleukin (IL)-2 receptor α-chain) and that depletion of CD4 + CD25 + T cells produces a variety of autoimmune diseases immunologically similar to the human counterparts [1] . This naturally arising CD4 + CD25
+ Treg population constitutes 5-10% of peripheral CD4 + T cells in normal naïve mice and humans. Depletion of CD4 to commensal bacteria in the intestine, causing inflammatory bowel disease (IBD), and evokes immune responses beneficial to the host, for example, effective tumor immunity and antimicrobial immunity. Conversely, when antigen-specific CD25 + CD4 + Treg cells are expanded, they are able to suppress allergy, establish tolerance to organ grafts, prevent graft-versus-host disease after bone marrow transplantation, and sustain fetomaternal tolerance. Thus, Foxp3 In addition to characteristic expression of cell surface molecules such as CD25, natural Treg cells specifically express the transcription factor Foxp3. Foxp3 is a master control gene for Treg development since expression of Foxp3 in normal naïve T cells converts them to Treg-like cells functionally and phenotypically. Genetic deficiency or dysfunction of Foxp3 is indeed causative of autoimmune disease such as type 1 diabetes, allergy, and immunopathology such as IBD in humans. Further, in the periphery, Foxp3
+ Treg cells with similar immunological properties with thymus-derived Treg cells can be generated from naïve T cells under certain conditions.
One of the key issues in current Treg cell research is to understand at the molecular level how Foxp3 + Treg cells are produced in the thymus and periphery and how they are capable of controlling such a variety of physiological and pathological immune responses against self and nonself. Obviously, Foxp3 + Treg cells bear antigen specificity, which is essential for their development in the thymus and periphery. In addition, they need to be activated by antigen via TCR to exert suppressive activity. In this review, we first summarize immunological characteristics of Treg cells and then discuss how TCR signaling contributes to the development and function of Foxp3 + Treg cells. We also review how Foxp3 operates in Treg cells.
Immunobiological characteristics of Treg cells
Foxp3 as a master regulator of Treg cell function Natural Treg cells specifically express Foxp3 [2] [3] [4] . The Foxp3 gene was first identified as a defective gene in the mouse strain Scurfy, which is an X-linked recessive mutant with lethality in hemizygous males and exhibit hyperactivation of CD4 + T cells and overproduction of proinflammatory cytokines [5] . In humans, mutations of Foxp3 result in deficiency or dysfunction of CD4 +
CD25
+ Treg cells, and thus cause the disease called immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome characterized by severe multiorgan autoimmune diseases, allergy, and IBD [6] . Foxp3 is preferentially expressed in CD4 + CD8 −
+ thymocytes and peripheral CD4 + CD25 + T cells in mice. It is a member of the forkhead/ winged-helix family of transcription factors, containing a highly conserved C-terminal winged-helix/forkhead DNAbinding domain, a C 2 -H 2 zinc finger, and a leucine zipper [7] . The N-terminal domain of Foxp3 is unique to the FOXP subfamily, and it is critical for transcriptional repression. Ectopic retroviral transduction of the Foxp3 gene in CD25 −
CD4
+ T cells can convert them to CD25 + CD4 + Treg-like cells that are able to suppress proliferation of other T cells in vitro and inhibit the development of autoimmune disease and IBD produced by Treg depletion [2, 3] . Foxp3 transduction in naïve T cells upregulates the expression of CD25 and other Treg-associated cell surface molecules, such as cytotoxic T lymphocyte-associated 4 (CTLA-4) and glucocorticoid-induced TNFR-related gene (GITR), and also represses the production of IL-2, interferon-gamma (IFN-γ), and IL-4. These characteristics are closely similar to those observed in natural Tregs. Thus, Foxp3 is so far the most reliable Treg marker with functional relevance.
Foxp3-dependent suppressive functions of Treg cells
Many possible mechanisms for Treg-mediated suppression have been proposed in the past decade [8, 9] . The contribution of cell contact-dependent mechanisms is suggested by the in vitro inability of Tregs to suppress the proliferation of responder T cells when the two populations are separated by a semipermeable membrane [10, 11] . Culture supernatant of antigen-stimulated Tregs also fails to exhibit suppressive activity. Following cell contact, Treg cells may kill responder T cells by a granzyme-dependent or perforin-dependent mechanism or deliver a negative signal to responder T cells leading to inhibition of T cell proliferation [12] [13] [14] . In addition, there is a possibility that IL-2 nonproduction by Foxp3 + Treg cells, together with their constitutive high expression of the high-affinity IL-2 receptor (IL-2R), makes Treg cells efficiently absorb IL-2 from the vicinity, thereby contributing to the hindrance of the activation/expansion of responder T cells [15] . Modification of APC function is also involved in the suppressive mechanisms. Activated Treg cells may downmodulate the expression of CD80 and CD86 on APCs, as well as stimulate DCs to express the enzyme indoleamine 2,3-dioxygenase (IDO) [16, 17] . IDO catabolizes conversion of the essential amino acid tryptophan to kynurenine, which is toxic to T cells neighboring the DCs. These processes appear to be dependent on CTLA-4 molecules expressed on the Treg cell surface. Activated Tregs can also kill APCs [18] .
In addition, Treg-mediated suppression involves secretion of suppressive humoral factors, such as IL-10, transforming growth factor-β (TGF-β), IL-35, and galectin-1 [8, 19, 20] . Although TGF-β and IL-10 are not required for Tregmediated suppression in vitro, they contribute, at least in part, to in vivo suppression of IBD induced in mice by Treg depletion [21, 22] . Furthermore, Treg cells, but not conventional T cells, secrete a novel inhibitory cytokine, IL-35, which is a member of the IL-12 family and a heterodimer comprised of Ebi3 and Il12α/p35 [23] . IL-35 production in Treg cells is substantially increased after the co-culture with effector T cells and required for maximal Treg function in vitro and in vivo.
Taken together, these in vivo and in vitro findings indicate that multiple mechanisms including cell contact and factormediated ones may operate in Treg-mediated suppression. It remains to be determined how each one contributes to in vivo suppression under different conditions and whether there is any core mechanism which is indispensable for sustaining self-tolerance and immune homeostasis [24] . In this regard, it is worth noting that the expression of Foxp3 can confer suppressive activity to non-Treg cells. Among the molecules discussed above, Foxp3 controls the expression of IL-2, CD25, and CTLA-4 by binding to their promoters. IL-2 or CD25 deficiency or Treg-specific CTLA-4 deficiency produces fatal autoimmunity/inflammation similar to the one observed in Foxp3 deficiency. Assuming that IL-2 and its signaling via IL-2R (CD25) are mainly required for Treg survival, a CTLA-4-dependent mechanism of suppression may constitute a core mechanism of suppression in vivo [25] .
Requirement of TCR stimulation for Treg-mediated suppression CD4 +
CD25
+ Treg cells require antigen stimulation via TCR to exert Treg suppressive function in vitro. Once activated by a specific antigen, Treg cells exhibit antigen-nonspecific suppression on the activation and expansion of other T cells [10] . For example, Treg cells specific for antigen A can be activated by an APC presenting antigen A; this antigen A-specific Treg cells can suppress the activation and expansion of not only antigen A-specific effector T cells but also antigen B-specific effector T cells recruited to the APC presenting both antigen A and B. That is, Treg cells are able to exert bystander suppression at least in vitro. Furthermore, with TCR transgenic mice, the concentration of antigenic peptide required to activate the peptide-specific Tregs to exert suppression in vitro is much lower (∼100 times) than the concentration needed for activating naïve T cells with the same antigen specificity [10] . This high antigen sensitivity of natural Treg cells can mainly be attributed to their high expression of accessory molecules including adhesion molecules such as leukocyte functionassociated molecule-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1), and also their "antigen-primed" or "semi-activated" state as suggested by high expression of CD44, CD25, GITR, folate receptor 4 (FR4), and CTLA-4 [26] [27] [28] . Indeed, in the presence of specific antigen, Treg cells outcompete with naïve T cells in forming aggregates around antigen-presenting DCs [25, 29] . This aggregation does not occur in the absence of antigen. This means that self-antigen-specific natural Tregs can be activated even by B7-low immature DCs that are presenting a low amount of self-peptide (for example, derived from ingesting apoptotic cells), even if the amount of the antigen is not sufficient to activate naïve self-reactive T cells. This is a key property of natural Treg cells engaged in dominant self-tolerance.
Cytokines: IL-2 for Treg survival and TGF-β for their peripheral induction
The constitutive high expression of CD25 is a key feature of Foxp3 + natural Treg cells [30] . In Treg cells, Foxp3 represses the transcription of Il2 and activates Cd25, making them highly dependent on exogenous IL-2 for their maintenance in the periphery [31] . Deficiency of IL-2, CD25, or CD122 produces fatal autoimmune/inflammatory disease, which is mainly due to defective survival of natural Treg cells [32] . In humans, CD25 deficiency also exhibits severe autoimmunity and allergy resulting from deficiency or dysfunction of Foxp3 + Treg cells [33] . In the thymus, Treg development is hampered by IL-2 deficiency especially when combined with deficiency of other γ c cytokines (e.g., IL-7 and IL-15) [34, 35] . In addition, IL-2 is required for sustained expression of Foxp3 and CD25 in natural Tregs and enhances their suppressive function, at least in vitro [34, 36] . Thus, Treg development and maintenance are highly dependent on IL-2 secreted by other subsets of lymphocytes, while Treg itself suppresses IL-2 production.
Treg cells are generated in several experimental conditions, for example, by in vitro antigenic stimulation of naïve T cells in the presence of TGF-β and IL-2 [37] . In this TGF-β-dependent Treg induction in vitro, IL-6 hampers the induction [38] . Interestingly, antigen stimulation in the presence of TGF-β and IL-6 facilitates differentiation of naïve T cells to Th17 cells in mice [39, 40] . IL-2 on the other hand inhibits the differentiation [41] . These findings indicate that TCR stimulation in the presence of particular combinations of cytokine is able to drive naïve T cells to differentiate to Treg cells as well as a variety of helper T cell subsets including Th1, Th2, and Th17 cells.
Cellular and molecular basis of Treg cell development and repertoire formation
The immunological features of Foxp3 + Treg cells discussed above indicate that TCR signal, together with other signals including cytokine, is essential for their development in the thymus and periphery. TCR signal may also turn on the expression of Foxp3 in developing T cells in the thymus.
Essential roles of TCR for Treg cell development
The observation that Treg cells do not develop in αβTCR transgenic mice deficient in recombination activating gene (RAG −/− ) strongly indicates that Treg cell development in the thymus requires TCR gene rearrangement at the TCR α-chain locus and resulting TCR specificities different from the transgenic TCR specificity. The number of Foxp3 + Treg cells in αβTCR and βTCR transgenic mice is substantially reduced, also suggesting that TCR specificity contributes to Treg cell development [26] . Moreover, a mutation in the gene encoding linker of activated T cell (LAT), a TCR proximal signal transduction molecule, abolishes the generation of Foxp3 + Tregs in the thymic and periphery while allowing the development of other T cells [42] . This indicates that Treg development requires a strong signal via the TCR in the thymus. Furthermore, in double-transgenic mice expressing a transgene-encoded peptide in the thymic stromal cells at a high level, the majority of T cells expressing transgenic α-and β-chains specific for the peptide differentiate to CD25 + CD4
+ T cells [43, 44] . A recent study also showed that inactivation of Lck, which blocks their capacity to signal through their TCRs, results in abnormal Treg homeostasis characterized by impaired turnover, preferential redistribution to the lymph nodes, and loss of suppressive function [45] . Altogether, these studies indicate that the TCR signaling is essential for the development of natural Treg cells in the thymus and their various functions including migration and suppression.
In addition to the signaling via TCR, costimulatory signal is required for the control of Treg development and homeostasis. For example, CD28-deficient mice develop a reduced number of Foxp3 + Treg cells [46] . Mice deficient in CD28 or B7-1/B7-2 on nonautoimmune-prone backgrounds display profoundly defective immune responses; however, CD28 or B7-1/B7-2-deficient mice on the diabetesprone NOD background develop a fulminant form of diabetes [47, 48] . Exacerbation of the disease is accompanied by a dramatic decrease in the percentage of CD4 + CD25
+ Treg cells in these mice. Furthermore, the occurrence of diabetes can be suppressed in NOD-CD28-deficient mice by injection of wild-type Treg cells [49] . These findings indicate that CD28-B7 interaction is critical for thymic generation and peripheral maintenance of Treg cells.
Requirement of thymic epithelial cells for Treg cell development
Development of Treg cells relies not only on TCR signal but also on signal from T cell accessory molecules interacting with thymic stromal cells. Most of Foxp3 + thymocytes are found in the thymic medulla, indicating that the differentiation of developing T cells to express Foxp3 occurs in the thymic medulla. At the cellular level, both medullary thymic epithelial cells (mTECs) and DCs in the thymus contribute to Treg generation/differentiation. For example, deficiency in tumor necrosis factor receptor-associated factor 6 or NF-kBinducing kinase results in the absence of mature mTECs, hampering the development of Tregs [50, 51] . A population of mTECs ectopically expresses a set of tissue-specific antigens (TSAs), such as insulin, under the control of the Aire (autoimmune regulator) gene [52] [53] . In these studies, restricting CD4 + T cells to solely express the transgenic TCR inhibits the formation of an effective Treg repertoire, allowing CD4 + T cells expressing the transgenic TCR to induce disease.
The diversity of TCRs displayed by Treg cells versus non-Treg cells has been assessed by sequencing Vα2-containing variable regions of the TCR α-chain from T cells purified from mice expressing a TCRβ transgene and a single copy of the TCR α-chain locus (Tcra +/− ) [54, 55] . In these studies, the degree of TCR repertoire diversity displayed by peripheral CD25 + and CD25 Based on these observations, it is likely that TCR engagement by a high-affinity self-ligand initiates signaling cascades that induce Foxp3 expression, which further drives thymocytes to the Treg cell lineage. Furthermore, several lines of evidence indicate that the availability of a "niche" for cognate antigen is important for the decision of Treg cell fate, generation, or elimination in thymus [57, 58] . The precise mechanism of this selection and differentiation of Foxp3 + Treg cells and stable maintenance of Foxp3 expression in Treg cells remain to be elucidated.
Another master for Treg cell development?
Although Foxp3 is recognized as the master of Treg development, recent studies suggest that Foxp3 is not required for the initial commitment of Treg cell lineage in the thymus. Using reporter mice in which the Foxp3 coding region is replaced by a green fluorescent protein (GFP) reporter, two groups have demonstrated that GFP-positive thymocytes, which do not express the Foxp3 protein, show some characteristics of the Treg phenotype including the expression of CD25, GITR, and CTLA-4, although they are not suppressive in vitro [59, 60] . This indicates that thymocytes are driven to the Treg lineage without Foxp3 and that once the Foxp3 gene is transcribed, Foxp3 may stabilize and sustain the Treg phenotype and confer suppressive activity. In addition, insulin-like 7, galectin-1, granzyme B, and helios genes are found to be specifically expressed in natural Treg, but independent of Foxp3 expression; for example, ectopic Foxp3 expression in conventional naïve T cells fails to up-or downregulate the expression of these genes in contrast with Foxp3-controlled CD25, CTLA-4, GITR, and other genes [59, 61, 62] . Furthermore, a cross-sectional analysis of the Treg cell signature in Treg-like cells generated under a number of conditions with or without Foxp3 has revealed that much of the Treg cell signature is not ascribable to Foxp3 [62] . These findings indicate that a higher level of regulation, which is independent of Foxp3, might exist in the Treg lineage commitment. Thus, it is intriguing to determine what mechanisms define the Treg differentiation program and turn on Foxp3 gene expression in developing thymocytes.
Molecular basis of Foxp3 induction and function

Factors required for Foxp3 induction
Foxp3 induction in Treg cells is controlled via a variety of signaling pathways involving TCR, IL-2, signal transducers and activators of transcription (STAT), Smad, TGF-β, phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR, and Notch. Upon TCR engagement with self-peptide/major histocompatibility complex ligands, Foxp3 expression is controlled by transcription factors that can bind to the promoter or enhancer regions of the Foxp3 gene. Within the 5′ flanking region of the Foxp3 transcription start site, there are several important transcription factor-binding sites, including those for AP-1 and nuclear factor of activated T cells (NFAT), along with typical sites of eukaryotic promoters including TATA and CAAT boxes. This region acts as the promoter for Foxp3 transcription and is referred to as the proximal promoter region, which is highly conserved over many species. Recent studies have shown that these NFAT and AP-1 binding sites positively regulate the transcriptional activation of the Foxp3 gene in response to TCR stimulation. NFAT and Smad3 binding sites also locate in an enhancer region of the Foxp3 gene [63] + T cells can be attributed to enhanced TGF-β driven phosphorylation of SMAD3 along with the inhibition of IL-6 and IL-23 receptor expression [68] .
Together, these findings indicate that several diverse intrinsic and extrinsic signals regulate Foxp3 expression and that TCR signaling can be a critical factor for Foxp3 induction.
Foxp3-dependent control of Treg function
Through genome-wide analysis combining chromatin immunoprecipitation with DNA microarray, Foxp3 binds to the regions for ∼700 genes, and a large number of Foxp3-bound genes are up-or downregulated in Foxp3 + cells [69] . The study suggests that Foxp3 acts as both a transcriptional activator and repressor. In another study, Foxp3 binds to forkhead motifs of about 1,100 genes in PMA/inomycin stimulated T cell hybridomas [70] . Most of the promoters occupied by Foxp3 in stimulated T cells are also occupied in unstimulated cells. However, the intensity of Foxp3 binding considerably increases at some promoters upon PMA/ionomycin stimulation. These findings are in line with observations that suppressive function of Tregs requires TCR engagement. Foxp3 binding genes are enriched for the genes involved in signaling pathways, cell communication, and transcriptional regulation, including those encoding cell surface molecules (e.g., Il2ra, Ctla4, and FasL), TCR signaling-related molecules (e.g., Zap70 and Ptpn22), transcription factors (e.g., Foxp3 itself), cytokines (e.g., Il2), enzymes for cell metabolism (e.g., Pde3b), and microRNAs (e.g., miR-155). Altogether, these genome-wide studies clearly show that Foxp3 controls a variety of physiological processes and functions as an activator as well as a repressor of transcription depending on the target genes.
Foxp3
+ Treg can also functionally differentiate to acquire an ability to control Th1, Th2, or Th17 type immune responses. For example, a fraction of Foxp3 + natural Treg expresses the Th1-specifying transcription factor T-bet in response to IFN-γ [71] . They upregulate CXCR3, a T-betcontrolled chemokine receptor, and then guide themselves to type 1 inflammation sites. In addition, Foxp3 directly controls the expression of the transcription factor IFN regulatory factor-4 (IRF-4), which is required for Th2 differentiation [72] . Interestingly, Treg-specific deletion of IRF-4 impairs the control of Th2, but not Th1 immune responses, resulting in spontaneous development of Th2 type inflammation. Moreover, a recent study shows that Foxp3 is associated with the transcriptionally active, phosphorylated form of Stat3, which is a critical transcription factor for Th17 differentiation [73] . Stat3 activation-dependent association with Foxp3 transcriptional complexes may result in modulation of Stat3-dependent gene expression in part through Stat3-dependent recruitment of Foxp3. Thus, the activation of Stat3 in Tregs endows them with the ability to suppress Th17 responses through increased expression of a subset of suppressor molecules as well as cytokine and chemokine receptors. In aggregates, Foxp3 modifies a transcriptional control of the lineage specific transcription factors and acquire an ability to control specific immune responses. Conversely, lineage specific transcription factors, such as T-bet, IRF-4, and Stat3 may facilitate Treg cell ability to suppress the corresponding type of the immune response.
Foxp3-interacting factors for the Foxp3-dependent transcription
Foxp3-dependent transcriptional regulation also requires other transcription factors along with chromatin-remodeling factors, histone deacetylase, and histone acetyltransferase, to perform accurate transcriptional regulation in Tregs [74] . To examine the Foxp3-dependent regulation, attempts have been made to find the molecules associated with Foxp3. These studies have revealed that Foxp3 interacts with the transcription factor NFAT, acute myeloid leukemia-1/runtrelated transcription factor 1 (Runx1), RAR-related orphan receptor C (RORγt), and Ikaros family zinc finger protein Eos, [75] [76] [77] [78] . Moreover, by MS/Qstar spectrometric analysis of the immunoprecipitated Foxp3 complex in ectopically Foxp3-expressing T cells, Foxp3 is shown to form a large transcriptional complex with several chromatin-remodeling factors including SWI/SNF-related, matrix-associated, actindependent regulator of chromatin, subfamily a, member 4 (BRG1); methyl-CpG binding domain protein 3 (MBD3); RuvB-like DNA helicases TIP49a and TIP49b; and ATPdependent DNA helicase II 70 kDa subunit Ku70 [74] . Those chromatin-remodeling factors co-fractionate precisely with Foxp3 in a large molecular weight complex. Tran-scriptional control exerted by Foxp3 also involves HATs, such as TIP60, and HDACs, such as HDAC7 and HDAC9. Acetylation of Foxp3 by TIP60 enhances the binding of Foxp3 to the Il2 promoter and augments the repression of Il2 [79] .
Thus, transcription complex containing Foxp3 might be a key to address the complexity of the expression of Tregassociated molecules, suppressive functions, and stability of Treg lineage. In the following sections, we will focus on the transcription factors NFAT, Runx1, RORγt, and Eos, all of which are shown to interact with Foxp3 and appear to play specific roles for Treg cells.
NFAT
The activity of NFAT is controlled by calcium and the calcium-dependent protein phosphatase calcineurin. In resting cells, these proteins are heavily phosphorylated and reside in the cytosol. TCR engagement results in the activation of the calmodulin-dependent phosphatase calcineurin, which binds to the N-terminus of NFAT and dephosphorylates multiple serine residues in the NFAT protein [80, 81] . After dephosphorylation, NFAT proteins translocate into the nucleus and initiate the transcription of NFAT-target genes [82] . Activated NFAT forms a complex with AP-1 and NF-kB and promotes the expression of IL2, IL4, Ctla4, and other genes in conventional T cells [83] . Thus, NFAT contribute to the activation of T cells and their differentiation to effector T cells.
A recent study has shown that Foxp3 can associate with NFAT, and the interaction between Foxp3 and NFAT is dependent upon their cooperative binding to DNA [75] . Crystal structure of a complex containing the forkhead domain of Foxp2 and the DNA-binding domain of NFAT1 demonstrates that Foxp proteins can associate with NFAT transcription factors in the transcriptional complexes [84] . These complexes bind to NFAT:AP-1 composite sites on the IL-2 promoter and likely displace NFAT:AP1 complexes, thereby directly repressing IL-2 transcription. Amino acid substitutions of Foxp3 that disrupt the Foxp3-NFAT interaction impair the ability of Foxp3 to repress Il2, activate Ctla4 and Cd25, and confer suppressive activity [84] . Thus, the interaction between NFAT and Foxp3 is essential for the function of Foxp3. In fact, mice deficient in both NFATc2 and NFATc3 spontaneously develop severe lymphoadenopathy and selective activation of Th2 cells, suggesting that the deficiency might disrupt the function of Foxp3 and consequently impair Treg function [85] .
Runx1
Runx proteins are transcription factors that have crucial roles for the development of many tissues and the immune system and form a family of evolutionarily conserved heterodimeric transcription factors [86] . Runx complexes are composed of unique DNA-binding α-subunits, Runx1, Runx2, or Runx3, which are homologues of the Drosophila runt gene. To form the functional complexes, they pair with the non-DNA-binding subunit core-binding factor β, Cbfβ, which has been shown to stabilize the interaction of Runx proteins with DNA. Targeted deletion of Runx subunits has revealed that Runx family proteins possess distinct roles for development. For example, Runx1 deletion is shown to be required for haemotopoiesis [87] and Runx3 for neurogenesis [88] .
In naïve T cells, Runx1 constitutively binds to the Il2 promoter at the site upstream to the binding sites of NFAT and AP-1 [76] . Upon T cell activation, Runx1 may act as an organizing factor that facilitates the assembly of active transcriptional complex on the Il2 promoter. On the other hand, in Treg cells, Runx1 has been shown to bind to Foxp3 at its N-terminal region in Tregs and play a role for Foxp3-mediated transcriptional regulation. Disrupting the binding between Foxp3 and Runx1 impairs the Foxp3-dependent suppression of IL-2 production and attenuates suppressive activity. Knockdown of Runx1 in natural Tregs abrogates their suppressive activity. These results suggest that the interaction between Runx1 and Foxp3 is essential for Treg function in vitro. Furthermore, Kitoh et al. have recently demonstrated that Treg-specific ablation of Cbfβ or Runx1, but not Runx3, causes autoimmune/inflammatory disease in mice [89] . Since the Cbfβ subunit acts as a binding partner for all Runx proteins, targeted inactivation of Cbfβ expression abrogates the activity of all Runx complexes [90, 91] . Treg-specific deficiency of Cbfβ induces lymphoproliferation, autoimmune disease, and hyperproduction of IgE. Similar Treg cell-specific gene targeting has revealed that the Runx and Cbfβ complex is required for the maintenance of Foxp3 mRNA and protein expression in Treg cells [92] . Indeed, Foxp3 expression in natural Treg cells correlates well with the binding of Runx/Cbfβ to regulatory elements within the Foxp3 locus. In addition, Cbfβ-deleted Treg cells exhibit impaired suppressive function in vitro and in vivo, with altered gene expression profiles including attenuated expression of Foxp3. Interestingly, Runx-binding sitedependent transactivation is observed only under activated condition, and not under unstimulated condition. These observations suggest that the Runx complex regulates constitutive Foxp3 expression rather than by transactivating the Foxp3 gene. In addition, Runx promotes de novo expression of Foxp3 during inducible Treg cell differentiation in vitro, and a dominant-negative Runt DNA-binding domain antagonized the de novo Foxp3 expression [93] . It has been shown that Runx1/Cbfb is not only a conventional transcriptional activator but also plays a critical role for properly guiding and forming Foxp3-containing transcrip-tional complex required for Foxp3-dependent transcription at specific DNA loci.
In line with the possible contribution of Runx1 to the Foxp3-mediated Treg function, there are some reports indicating the importance of Runx family in autoimmunity (Fig. 1) . Runx3-deficient mice spontaneously develop IBD and hyperplastic gastritis-like lesions, which are immunologically similar to those produced by Treg depletion [94, 95] . Disease-associated regulatory single nucleotide polymorphisms (SNPs) affecting the consensus sites for Runx1 are associated with genetic susceptibility to several autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis, and psoriasis [96] [97] [98] . In addition, an SNP in the Runx1 gene itself is strongly associated with rheumatoid arthritis [98] . It is thus likely that genetic anomalies of Runx family may contribute to the development of autoimmune disease and other immunological diseases by means of affecting Treg-mediated immune regulation.
RORγt
Foxp3 also appear to interact with RORγt, a key transcription factor for the differentiation of naïve T cells to Th17 cells characterized by the production of IL-17A, IL-17F, IL-21, and IL-22 [77] . Th17 cells play a key effector part in autoimmune diseases, elimination of extracellular bacteria, and cancer [99] [100] [101] . RORγt-mediated IL-17A promoter activation is suppressed by forced expression of Foxp3, and Foxp3 directly interacts with RORγt through exon2 region of Foxp3. Thus, the interaction between Foxp3 and RORγt might be important for the suppression of Th17 and polarization into induced Tregs. While Th17 differentiation of naïve T cells is initiated by IL-6 and TGF-β [39, 40, 102] , TGF-β also drives the conversion of naïve T cells to Foxp3 + Treg cells [103] . This suggests that the presence or absence of proinflammatory cytokines might lead to opposing immune consequences induced by TGF-β, and the interaction between RORγt and Foxp3 may be involved in the regulation of the Th17-Treg balance.
Eos
One important feature of Treg cells is selective gene silencing of cytokine genes such as IL-2 and IFN-γ. It has been shown recently that Eos, a member of the Ikaros family, is a critical mediator of Foxp3-dependent gene silencing in Tregs [78] . The Ikaros family consists of zinc finger type transcription factors including Ikaros, Aiolos, Helios, and Eos. Some of them are expressed in lymphocytes and have been implicated in controlling lymphoid development. These proteins contain two characteristic clusters of zinc fingers, an N-terminal domain important for DNA recognition, and a C-terminal domain that mediates homo-and heterodimeric associations between family members. Eos can interact with Foxp3 and induces chromatin modifications that result in gene silencing in Treg cells. Knockdown of Eos in Treg cells abrogates their ability to suppress immune responses, suggesting critical role of Eos in Treg programming. Interestingly, Eos is involved in the Foxp3-dependent gene repression, but not in the activation, suggesting that Foxp3 suppresses gene expression through its interaction with Eos. Eos also interacts with C-terminal binding protein-1 (CtBP1), which has been shown to suppress transcription by affecting histone methylation and acetylation [104] . Thus, CtBP1 is implicated as a key repressor of Eos-mediated gene expression as a component of corepressor complexes, and the complexes containing Eos, CtBP1, and Foxp3 may control the epigenetic status of the Foxp3-target genes.
Epigenetic control of Treg cells
Treg cells show hypoproliferation upon TCR stimulation in vitro, whereas natural Treg cells are continuously proliferating in vivo presumably through recognition of self-antigen and commensal microbes [31, 105] . Compared to naïve T cells, Treg cells specifically and continuously express a set of genes, such as Il2ra (CD25), Ctla4, and Gitr. [106] . It suggests that a more complete CpG demethylation Fig. 1 A possible mechanism of Foxp3-mediated regulatory T cells (Treg) function. Upon T cell receptor engagement with self-peptide/ major histocompatibility complex ligands, transcriptional factors that bind to the promoter or enhancer region of the Foxp3 gene control Foxp3 expression. Foxp3-dependent transcriptional regulation also requires direct interaction with other transcription factors including NFAT, Runx1, RORγt, and Eos. These interactions are critical for Treg function and development may be required for a stable Foxp3 expression. In addition, naïve T cells in humans readily express Foxp3 upon TCR stimulation, although the expression is generally much lower and more transient than in natural Tregs, suggesting that incomplete demethylation of the Foxp3 gene affects Foxp3 expression levels and its sustained expression. Consistent with these findings, demethylation induced by 5-azacytidine in human NK cells leads to induction of Foxp3 [107] , and deficiency of DNA methyltransferase 1 (Dnmt1) induces enhancement of Foxp3 expression [108] . Thus, constitutive expression of Foxp3 in natural Tregs is controlled by DNA methylation of CpG islands in the Foxp3 gene, and control of DNA methylation at the Foxp3 locus is essential for establishing Treg cell lineage.
Foxp3 gene
Apart from inheritance of methylated CpG residues in genomic DNA, parental histone molecules can also divide and be transmitted to the progeny cells. TCR stimulation induces H3-K4 di-and trimethylation at the Foxp3 promoter and intronic enhancer regions after 18 h of stimulation of naïve CD4 + T cells. This is in line with the observations that Foxp3 expression in CD4 + T cells is controlled by TCR signaling, and the Foxp3 promoter and enhancer are also H3-K4 methylated in Tregs. Therefore, the TCR stimulation may initially affect the histone code of the Foxp3 gene, thereby leading to the establishment of epigenetic status of Treg cells.
Moreover, demethylation of the Foxp3 promoter region and the CpG island in the enhancer is important for the induction of Foxp3. Demethylation of the regions is controlled, at least in part, by signaling from TGF-β and TCR. The finding is in line with the observation that Foxp3 gene expression can be readily induced in CD4 +
CD25
− T cells by stimulation with TGF-β, anti-CD3, and anti-CD28. A TGF-β response element, however, has not been identified in the Foxp3 gene or in surrounding regions, suggesting that TGF-β may modulate expression profiles of factors related to epigenetic control. The importance of TCR signaling in Foxp3 induction is also shown by using a genetic model of DNA methyltransferase 1 (Dnmt1) deficiency. In Dnmt1 knockout mice, TCR stimulation can induce Foxp3 expression at a high level [108] . Moreover, in the absence of Dnmt1, Foxp3 induction in thymic and peripheral Foxp3-negative T cells is maximized upon TCR stimulation, and the provision of TGF-β is dispensable for Foxp3 expression. These observations suggest that the TCR signal is sufficient for transcriptional activation of Foxp3 in the absence of maintenance DNA methylation.
Concluding remarks
Treg cells have been shown to suppress a variety of physiological and pathological immune responses through multiple mechanisms. Over the last decade, considerable progress has been made in elucidating molecular mechanisms underlying Treg development and differentiation. A key finding for understanding Treg development and function at the molecular level is the identification of Foxp3 as a hallmark of this population of suppressor cells. Since Foxp3 can confer Treg suppressive activity to conventional CD4 + T cells, Foxp3-dependent regulation and Foxp3 induction itself are expected to be appropriate targets for the manipulation of Treg activities. In addition, TCR signaling plays prominent roles for the differentiation and selection of Treg cells, hence the formation of their TCR repertoire. Impairment or augmentation of Foxp3-dependent regulation or TCR signaling can alter the balance between Treg and effector T cells, leading to impaired peripheral self-tolerance and immune homeostasis. Pharmacological treatments that aim to modulate the balance between Treg and effector T cells will provide the novel therapeutic strategies in the treatment of immunological diseases.
